Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences
Abstract
:1. Introduction
2. HAT Elimination in DR Congo
3. Materials and Methods
4. Results
4.1. Work at the Frontline
“in the time of Mobutu [in the 1970s?] the authorities would fine those who did not come to us, so people came en masse, as they feared to be arrested. But now, the authorities don’t do that. […] now it is difficult to get people as the authorities do not get involved”(8, mobile unit)
“When I started working, I was not married yet. I married ‘in’ [dans] sleeping sickness, I got children in sleeping sickness, I schooled my children in sleeping sickness, I built [my house] in sleeping sickness. I could say a good part of my life is built on sleeping sickness”(15, frontline non-mobile)
“[what I like most about HAT is] the family of the fight against Trypanosomiasis that we have been able to have. Wherever we went, we met people who are in this fight; it really gives us joy; it’s really great memory for me, unforgettable because we met a lot of people, of all categories and even some people from foreign countries”(18, management)
“my children have studied, my eldest will soon become a doctor, he is studying in Kinshasa […]. I have also bought a plot of land here in Bandundu.”(20, mobile unit)
“well, I can say that with the little they give me at the end of the month, that’s what allows me to have my children study […], so, in short, my children study.”(2, mobile unit)
4.2. Perspectives on Elimination
“The large forests where tsetse flies used to hide are being pulled up, people are starting to cultivate the fields there, they are making small ponds; and even here in the village, there are no tsetse flies left.”(14, frontline non-mobile)
“Sleeping sickness can be eliminated, but it will be like leprosy. [They told us it is eliminated but] I saw the people here in Bandundu who don’t have toes. When I asked the question, I was told that there was a disease called leprosy, Maba’s disease. Even today, we, the mobile unit, have friends who are on the leprosy and tuberculosis programme.”(1, mobile unit)
“to eliminate the disease, two problems need to be solved. First of all, on the molecular side, we have succeeded, we have molecules that are really good. [...] the treatment [NECT] is not as toxic as before [Arsobal]. [The other side is] our explanations in the villages [...] there will be no elimination until everyone understands [can identify] sleeping sickness.”(8, mobile unit)
“It is more a question of organisation than just tools. The tools may be there, but if they are not properly used or if the conditions of use of these tools are not met, elimination will not be achieved.”(10, management)
“Up to now our population, the whole of our population, is not sensitive to active screening. They have their reasons. There are some people who say that sleeping sickness is sometimes transmitted by us, the agents, by evil spirits.”(7, mobile unit)
“The political-administrative authorities [likely referring to the leaders mentioned earlier] are not so much listened to by the population. […] The population trusts us, but I tell you, the population no longer really trusts the agents of the state [government and administrators], but we greatly need them because the population belongs to them, we must go through their channel to try to take care of their population.”(5, mobile unit)
“give people a motivation [understood as a financial incentive in this context] to access people in the villages where we go, because we are dealing with village chiefs, elders, religious leaders and community relays, they are the ones who help us to do our job well. Motivation is one of the realities we encounter in the field in villages”(2, mobile unit)
“The decrease in [reported] cases, here I would just like to explain that it is not necessarily related to [a true] decrease in endemicity. So endemicity may still exist, but since the level of control has decreased due to lack of resources, it may also explain the decrease in the number of cases.”(18, management)
“[When asked about the possibility of elimination by 2020] That is a firm no. We do not yet know how to reach it because, so far, we only have coverage of the population at high risk. We know that currently with the WHO we have categorized the high-risk, medium-risk and low-risk areas, but when we take the areas of active screening together, we do not go well beyond 20% of the population.”(9, management)
“Secondly, in this same population, you will try to set traps wherever there are tsetse flies. We educate them [the population] but these same traps are stolen by the same population […], even if you designate people to monitor these traps and catch tsetse flies […] they ask for money, they must be motivated.”(7, mobile unit)
4.3. Personal Effects of Elimination
“The people in the mobile units are not afraid; they say that the work will not end because the disease will not end. […even if] the programme (PNLTHA) tends towards the end; the disease will not end; it is since the creation”(16, frontline non-mobile)
“I am in a new unit without a personnel number [unregistered, non-mécanisé], that’s something that scares me; I can become unemployed in that sense. But I know that whoever gave me this job knows how he’s going to use me. If he is tired of me, I will do agriculture; I will fish if I still have the strength.”(2, mobile unit)
“I’m a registered and ‘unpaid’ [by the Ministry of Health, non-payé] employee, but we’ll always go to the inspection [provincial health authorities], or we’ll manage. There is always life.”(1, mobile unit)
“[…] it worries us; it must worry us because where you were able to afford school fees for children, you are stuck with that. […] As you are given something that is not sufficient enough, you try to find a way, but then you will get used to it.”(15, frontline non-mobile)
“The majority of our service providers, our employees, they are under-qualified, and they will have a lot of difficulties to learn other knowledge. We have a vast project for them that will involve training people, obtaining scholarships […], on-the-job training for everyone, […] not specific to sleeping sickness. […]. And thirdly, we believe that for our staff, as many of them, we must obtain the mecanisé status [have them on the ministry books].”(10, management)
“We always ask the chief doctors of the zones whether it is the vaccination period and whether they can take people from the mobile units so that they can also immerse themselves in other stories [other contexts] so that when the time comes, they will still be useful to Congolese society.”(18, management)
5. Discussion
6. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Appendix A. Interview Guide
- Could you briefly tell us about who you are, how and when you started working in sleeping sickness?
- What have been your main responsibilities in the fight against sleeping sickness so far?
- In your role you visit several places where there is sleeping sickness, considering its current evolution, do you think that we will eliminate sleeping sickness
- Currently we are talking about the elimination of the HAT by 2020, do you think this objective is achievable in the DRC?
- What does it mean for you to be on the ground when it comes to the elimination of sleeping sickness in the DRC?
- Some interviewees say that innovations in HAT treatment, diagnosis and new screening approaches are needed to eliminate sleeping sickness. Others, on the other hand, believe that even if there are innovations if the coverage of the population at risk remains low, elimination will not be possible. What are you saying?
- Some interviewees say that you members of the mobile teams and HAT treatment centre are afraid of the elimination of sleeping sickness for fear of losing your job when the disease disappears?
- If tomorrow sleeping sickness were to disappear, what would you do?
- Do you control diseases other than HAT? Is there anything else your team could do that you think your team could do?
- In your opinion, what are the major challenges to eliminating sleeping sickness in the DRC?
References
- Barrett, M.P. The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis. PLoS Negl. Trop. Dis. 2018, 12, e0006925. [Google Scholar] [CrossRef] [PubMed]
- Miaka, E.M.; Hasker, E.; Verlé, P.; Torr, S.J.; Boelaert, M. Sleeping sickness in the Democratic Republic of the Congo. Lancet Neurol. 2019, 18, 988–989. [Google Scholar] [CrossRef]
- Akazue, P.I.; Ebiloma, G.U.; Ajibola, O.; Isaac, C.; Onyekwelu, K.; Ezeh, C.O.; Eze, A.A. Sustainable Elimination (Zero Cases) of Sleeping Sickness: How Far Are We from Achieving This Goal? Pathogens 2019, 8, 135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Simarro, P.P.; Jannin, J.; Cattand, P. Eliminating human African trypanosomiasis: Where do we stand and what comes next? PLoS Med. 2008, 5, e55. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wamboga, C.; Matovu, E.; Bessell, P.R.; Picado, A.; Biéler, S.; Ndung’u, J.M. Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda—Moving towards elimination. PLoS ONE 2017, 12, e0186429. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mesu, V.K.B.K.; Kalonji, W.M.; Bardonneau, C.; Mordt, O.V.; Blesson, S.; Simon, F.; Delhomme, S.; Bernhard, S.; Kuziena, W.; Lubaki, J.P.F.; et al. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: A pivotal multicentre, randomised, non-inferiority trial. Lancet 2018, 391, 144–154. [Google Scholar] [CrossRef]
- Alirol, E.; Schrumpf, D.; Amici Heradi, J.; Riedel, A.; De Patoul, C.; Quere, M.; Chappuis, F. Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo. Clin. Infect. Dis. 2013, 56, 195–203. [Google Scholar] [CrossRef]
- Jamonneau, V.; Bucheton, B. The challenge of serodiagnosis of sleeping sickness in the context of elimination. Lancet Glob. Health 2014, 2, e306–e307. [Google Scholar] [CrossRef] [Green Version]
- Cattand, P.; Jannin, J.; Lucas, P. Sleeping sickness surveillance: An essential step towards elimination. Trop. Med. Int. Health 2001, 6, 348–361. [Google Scholar] [CrossRef] [Green Version]
- Palmer, J.J.; Kelly, A.H.; Surur, E.I.; Checchi, F.; Jones, C. Changing landscapes, changing practice: Negotiating access to sleeping sickness services in a post-conflict society. Soc. Sci. Med. 2014, 120, 396–404. [Google Scholar] [CrossRef] [Green Version]
- Tong, J.; Valverde, O.; Mahoudeau, C.; Yun, O.; Chappuis, F. Challenges of controlling sleeping sickness in areas of violent conflict: Experience in the Democratic Republic of Congo. Confl. Health 2011, 5, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Lumbala, C.; Simarro, P.P.; Cecchi, G.; Paone, M.; Franco, J.R.; Betu Ku Mesu, V.K.; Makabuza, J.; Diarra, A.; Chansy, S.; Priotto, G.; et al. Human African trypanosomiasis in the Democratic Republic of the Congo: Disease distribution and risk. Int. J. Health Geogr. 2015, 14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Loevinsohn, B.; Aylward, B.; Steinglass, R.; Ogden, E.; Goodman, T.; Melgaard, B. Impact of targeted programs on health systems: A case study of the polio eradication initiative. Am. J. Public Health 2002, 92, 19–23. [Google Scholar] [CrossRef] [PubMed]
- Kingori, B.P.; Mcgowan, C. After the End of Ebola. Somatosphere 2016. Available online: http://somatosphere.net/2016/after-the-end-of-ebola.html/ (accessed on 28 December 2019).
- Lutumba, P.; Robays, J.; Bilenge, C.M.M.; Mesu, V.K.B.K.; Molisho, D.; Declercq, J.; Van Der Veken, W.; Meheus, F.; Jannin, J.; Boelaert, M. Trypanosomiasis control, Democratic Republic of Congo, 1993–2003. Emerg. Infect. Dis. 2005, 11, 1382–1388. [Google Scholar] [CrossRef]
- Courtin, F.; Jamonneau, V.; Duvallet, G.; Garcia, A.; Coulibaly, B.; Doumenge, J.P.; Cuny, G.; Solano, P. Sleeping sickness in West Africa (1906–2006): Changes in spatial repartition and lessons from the past. Trop. Med. Int. Health 2008, 13, 334–344. [Google Scholar] [CrossRef]
- Brun, R.; Blum, J.; Chappuis, F.; Burri, C. Human African trypanosomiasis. Lancet 2010, 375, 148–159. [Google Scholar] [CrossRef] [Green Version]
- PNLTHA. Rapport Annuel 2018 Du Programme National De Lutte Contre La THA En RDC; Ministry of Health: Kinshasa, Democratic Republic of the Congo, 2018.
- Franco, J.R.; Simarro, P.P.; Diarra, A.; Jannin, J.G. Epidemiology of human African trypanosomiasis. Clin. Epidemiol. 2014, 6, 257–275. [Google Scholar]
- Franco, J.R.; Cecchi, G.; Priotto, G.; Paone, M.; Diarra, A.; Grout, L.; Mattioli, R.C.; Argaw, D. Monitoring the elimination of human African trypanosomiasis: Update to 2014. PLoS Negl. Trop. Dis. 2017, 11, e0005585. [Google Scholar] [CrossRef]
- Davidson, K. DRC Government Steps Up Commitment to Eliminating Sleeping Sickness by 2020. 2018 (31 Januray). Available online: https://www.path.org/media-center/drc-government-steps-up-commitment-to-eliminating-sleeping-sickness-by-2020/ (accessed on 28 December 2019).
- PNLTHA. Rapport Annuel 2016 Du Programme National De Lutte Contre La THA En RDC; Ministry of Health: Kinshasa, Democratic Republic of the Congo, 2016.
- Mitashi, P.; Hasker, E.; Mbo, F.; Van Geertruyden, J.P.; Kaswa, M.; Lumbala, C.; Boelaert, M.; Lutumba, P. Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the democratic republic of the congo. Trop. Med. Int. Health 2015, 20, 98–105. [Google Scholar] [CrossRef] [Green Version]
- Mulenga, P.; Boelaert, M.; Lutumba, P.; Vander Kelen, C.; Coppieters, Y.; Chenge, F.; Lumbala, C.; Luboya, O.; Mpanya, A. Integration of Human African trypanosomiasis control activities into primary health services in the democratic republic of the Congo: A qualitative study of stakeholder perceptions. Am. J. Trop. Med. Hyg. 2019, 100, 899–906. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jannin, J.; Moulia-Pelat, J.P.; Chanfreau, B.; Penchenier, L.; Louis, J.P.; Nzaba, P.; Elfassi De La Baume, F.; Eozenou, P.; Cattand, P. Trypanosomiase Humaine Africaine: Etude D’Un Score De Presomption De Diagnostic Au Congo. Bull. World Health Organ. 1993, 71, 215–222. [Google Scholar] [PubMed]
- Palmer, J.J. The HAT diagnostic reflex: How do we instil this for elimination? Trop. Med. Infect. Dis. submitted.
- Magnus, E.; Vervoort, T.; Van Meirvenne, N. A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. b. gambiense trypanosomiasis. Ann. Soc. Belg. Med. Trop. (1920) 1978, 58, 169–176. [Google Scholar]
- Büscher, P.; Gilleman, Q.; Lejon, V. Rapid Diagnostic Test for Sleeping Sickness. N. Engl. J. Med. 2013, 368, 1068–1069. [Google Scholar] [CrossRef] [PubMed]
- WHO. Trypanosomiase Humaine Africaine: Lutte Et Surveillance. Rapports Techniques d’un comité d’experts l’OMS 2013, 984, 1–255. [Google Scholar]
- Franco, J.R.; Simarro, P.P.; Diarra, A.; Ruiz-Postigo, J.A.; Samo, M.; Jannin, J.G. Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis. Res. Rep. Trop. Med. 2012, 3, 93. [Google Scholar] [CrossRef] [Green Version]
- Mahamat, M.H.; Peka, M.; Rayaisse, J.B.; Rock, K.S.; Toko, M.A.; Darnas, J.; Brahim, G.M.; Alkatib, A.B.; Yoni, W.; Tirados, I.; et al. Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad). PLoS Negl. Trop. Dis. 2017, 11, e0005792. [Google Scholar] [CrossRef]
- Lumbala, C.; Biéler, S.; Kayembe, S.; Makabuza, J.; Ongarello, S.; Ndung’u, J.M. Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens. PLoS Negl. Trop. Dis. 2018, 12, e0006386. [Google Scholar] [CrossRef] [Green Version]
- Lutumba, P.; Makieya, E.; Shaw, A.; Meheus, F.; Boelaert, M. Human African trypanosomiasis in a rural community, Democratic Republic of Congo. Emerg. Infect. Dis. 2007, 13, 248–254. [Google Scholar] [CrossRef]
- Wenzel Geissler, P.; Lachenal, G.; Manton, J.; Tousignant, N. Traces of the Future: An Archaeology of Medical Science in Africa; Intellect: Bristol, UK, 2016. [Google Scholar]
- Molyneux, D.H.; Hopkins, D.R.; Zagaria, N. Disease eradication, elimination and control: The need for accurate and consistent usage. Trends Parasitol. 2004, 20, 347–351. [Google Scholar] [CrossRef] [PubMed]
- Mulenga, P.; Lutumba, P.; Coppieters, Y.; Mpanya, A.; Mwamba-Miaka, E.; Luboya, O.; Chenge, F. Passive Screening and Diagnosis of Sleeping Sickness with New Tools in Primary Health Services: An Operational Research. Infect. Dis. Ther. 2019, 8, 353–367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Greenough, P. Intimidation, coercion and resistance in the final stages of the South Asian Smallpox Eradication Campaign, 1973–1975. Soc. Sci. Med. 1995, 41, 633–645. [Google Scholar] [CrossRef]
- Bhattacharya, S.; Dasgupta, R. Smallpox eradication’s lessons for the antipolio campaign in India. Am. J. Public Health 2009, 99, 1176–1184. [Google Scholar] [CrossRef] [PubMed]
- Larson, H.J.; Ghinai, I. Lessons from polio eradication. Nature 2011, 473, 446–447. [Google Scholar] [CrossRef]
- Palmer, J.J.; Robert, O.; Kansiime, F. Including refugees in disease elimination: Challenges observed from a sleeping sickness programme in Uganda. Confl. Health 2017, 11, 22. [Google Scholar] [CrossRef] [Green Version]
- Closser, S.; Rosenthal, A.; Justice, J.; Maes, K.; Sultan, M.; Banerji, S.; Amaha, H.B.; Gopinath, R.; Omidian, P.; Nyirazinyoye, L. Per diems in polio eradication: Perspectives from community health workers and officials. Am. J. Public Health 2017, 107, 1470–1476. [Google Scholar] [CrossRef]
- Ridde, V. Per diems undermine health interventions, systems and research in Africa: Burying our heads in the sand. Trop. Med. Int. Health 2010, 15, E1–E4. [Google Scholar] [CrossRef]
- Sutherland, C.S.; Tediosi, F. Is the elimination of sleeping sickness’ affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa. BMJ Glob. Health 2019, 4, e001173. [Google Scholar] [CrossRef] [Green Version]
- Standley, C.; Boyce, M.R.; Klineberg, A.; Essix, G.; Katz, R. Organization of oversight for integrated control of neglected tropical diseases within Ministries of Health. PLoS Negl. Trop. Dis. 2018, 12, e0006929. [Google Scholar] [CrossRef] [Green Version]
- Brandt, C. Teachers’ Struggle for Income in the Congo (DRC). Between Education and Remuneration. SSRN Electron. J. 2019. Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3316289 (accessed on 28 December 2019).
- Lee, S.J.; Palmer, J.J. Integrating innovations: A qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in Uganda’s human African trypanosomiasis elimination programme. Infect. Dis. Poverty 2018, 7, 1–16. [Google Scholar] [CrossRef] [PubMed]
- Mulenga, P.; Chenge, F.; Boelaert, M.; Mukalay, A.; Lutumba, P.; Lumbala, C.; Luboya, O.; Coppieters, Y. Integration of human African trypanosomiasis control activities into primary healthcare services: A scoping review. Am. J. Trop. Med. Hyg. 2019, 101, 1114–1125. [Google Scholar] [CrossRef] [PubMed]
Category | Role | Gender | Experience | Interview Number |
---|---|---|---|---|
mobile unit | 2 Community outreach workers 1 Secretary 2 Technicians (lab) 6 Leaders (nurse/technician, chef d’équipe mobile) | all males | 28 years (SD: 10.9) | 1, 2 17 20, 21 3–8 |
Frontline non-mobile | 4 HAT centre (CDTC) chief nurse 2 HAT hospital centre chief nurse | all males | 25.8 (6.37) | 11–14 15–16 |
management | 2 HAT provincial management (supervisor) 2 HAT provincial management (coordinator) | all males | 31 (9.89) 11.5 (2.12) | 18, 19 9, 10 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Falisse, J.-B.; Mwamba-Miaka, E.; Mpanya, A. Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences. Trop. Med. Infect. Dis. 2020, 5, 6. https://doi.org/10.3390/tropicalmed5010006
Falisse J-B, Mwamba-Miaka E, Mpanya A. Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences. Tropical Medicine and Infectious Disease. 2020; 5(1):6. https://doi.org/10.3390/tropicalmed5010006
Chicago/Turabian StyleFalisse, Jean-Benoît, Erick Mwamba-Miaka, and Alain Mpanya. 2020. "Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences" Tropical Medicine and Infectious Disease 5, no. 1: 6. https://doi.org/10.3390/tropicalmed5010006
APA StyleFalisse, J. -B., Mwamba-Miaka, E., & Mpanya, A. (2020). Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences. Tropical Medicine and Infectious Disease, 5(1), 6. https://doi.org/10.3390/tropicalmed5010006